title: Technology behind commercial devices for blood glucose monitoring in diabetes management: a review.
abstract: The blood glucose monitoring devices (BGMDs) are an integral part of diabetes management now-a-days. They have evolved tremendously within the last four decades in terms of miniaturization, rapid response, greater specificity, simplicity, minute sample requirement, painless sample uptake, sophisticated software and data management. This article aims to review the developments in the technologies behind commercial BGMD, especially those in the areas of chemistries, mediators and other components. The technology concerns, on-going developments and future trends in blood glucose monitoring (BGM) are also discussed.
authors: NUSNNI-NanoCore, National University of Singapore, T-Lab Level 11, 5A Engineering Drive 1, Singapore 117580, Singapore.
authors: Sandeep Kumar
authors: SK
authors: Vashist
authors: Dan
authors: D
authors: Zheng
authors: Khalid
authors: K
authors: Al-Rubeaan
authors: John H T
authors: JH
authors: Luong
authors: Fwu-Shan
authors: FS
authors: Sheu
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation* / Q000379:methods / Q000639:trends; D003920:Diabetes Mellitus / Q000097:blood*; D004798:Enzymes / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008567:Membranes, Artificial; D010084:Oxidation-Reduction
chemical_list: D001786:Blood Glucose; D004798:Enzymes; D008567:Membranes, Artificial